Skip to main content
Michael Birrer, MD, Oncology, Little Rock, AR

Michael James Birrer MD Ph.D.

Oncology•Little Rock, AR

Professor, Department of Medicine Harvard Medical School Director Gynecologic Medical Oncology

Join to View Full Profile

  • UAMS Medical Center449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Second FloorLittle Rock, AR 72205

  • Phone+1 501-686-8522

Dr. Birrer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Birrer's Full ProfileAlready have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1982 - 1985
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1982

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1900 - Present
  • AR State Medical License
    AR State Medical License 2019 - 2026
  • AL State Medical License
    AL State Medical License 2017 - 2019
  • MA State Medical License
    MA State Medical License 1984 - 2019
  • MD State Medical License
    MD State Medical License 1985 - 2010
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Boston Magazine Castle Connolly, 2010-2013
  • America's Top Doctors for Cancer Castle Connolly, 2010-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase Ib Study of Mirvetuximab Soravtansine, a Folate Receptor Alpha (FRα)-Targeting Antibody-Drug Conjugate (ADC), in Combination with Bevacizumab in Patients with Pl...  
    David M O'Malley, Ursula A Matulonis, Michael J Birrer, Cesar M Castro, Lainie P Martin, Kathleen N Moore, Gynecologic Oncology
  • Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)  
    Alessandro D Santin, Michael Frumovitz, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology
  • Primordial Germ Cells as a Potential Shared Cell of Origin for Mucinous Cystic Neoplasms of the Pancreas and Mucinous Ovarian Tumors  
    Leona A Doyle, Daniel W Cramer, Michael Goggins, Ronny Drapkin, Jason L Hornick, Kevin M Elias, Michael Birrer, Michelle S Hirsch, The Journal of Pathology
  • Join now to see all

Other

Press Mentions

  • UAMS College of Medicine Honors Shuk-Mei Ho, Ph.D., as Distinguished Faculty Scholar
    UAMS College of Medicine Honors Shuk-Mei Ho, Ph.D., as Distinguished Faculty ScholarOctober 24th, 2024
  • Bispecific Antibody Provides Long-Term Responses in Some Advanced Cervical Cancers
    Bispecific Antibody Provides Long-Term Responses in Some Advanced Cervical CancersJuly 31st, 2024
  • Arkansas to Send Reserve Funds to UAMS for Cancer Center, Redirect Medical Marijuana Tax
    Arkansas to Send Reserve Funds to UAMS for Cancer Center, Redirect Medical Marijuana TaxApril 13th, 2023
  • Join now to see all

Grant Support

  • Novel Biomarkers In Ovarian CancerNational Cancer Institute2010–2012
  • Proteomic, Genetic &Longitudinal Pathways To Ovarian Cancer Biomarker DiscoveryNational Cancer Institute2010–2011
  • Genomic Stratification Of Ovarian Cancer PatientsNational Cancer Institute2010
  • The Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisDivision Of Clinical Sciences - Nci2009
  • The Molecular Genetics Of Gynecologic CancersDivision Of Clinical Sciences - Nci2009
  • The Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisNational Cancer Institute2007–2008
  • The Molecular Genetics Of Gynecologic CancersNational Cancer Institute2007–2008
  • The Use Of Transcriptional Factors As Targets And AgentsDivision Of Clinical Sciences - Nci2002–2006
  • The Molecular Mechanisms Of Oncogene ActionDivision Of Clinical Sciences - Nci1996–2006
  • The Molecular Genetics Of Gynecologic CancersDivision Of Clinical Sciences - Nci1996–2006
  • Transcriptional Factors As Targets And Agents In Carcin.Division Of Clinical Sciences - Nci2004
  • Use Of Transcriptional Factors As Targets And AgentsDivision Of Clinical Sciences - Nci2001
  • Molecular Mechanisms Of Oncogene ActionDivision Of Clinical Sciences - Nci2001
  • Molecular Genetics Of Gynecologic CancersDivision Of Clinical Sciences - Nci2001
  • The Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisDivision Of Clinical Sciences - Nci1999–2000
  • Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisDivision Of Clinical Sciences - Nci1997–1998
  • Transcriptional Factors As Targets And Agents For ChemopreventionDivision Of Clinical Sciences - Nci1996

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Michael Birrer, Dr. Michael Birrer, MD, Dr. M Birrer, Dr. Michael James Birrer